Contraindications

Do not prescribe HRT in women with:

• Current, past or suspected breast cancer.
• Current, past or suspected ductal carcinoma in situ (DCIS).
• Current, past or suspected oestrogen dependent cancer.
• Undiagnosed vaginal bleeding.
• Untreated endometrial hyperplasia.
• Active or recent arterial thromboembolic disease.
• Active liver disease with abnormal liver function tests.
• Pregnancy.

Prescribe HRT with caution in women with:

• Women at increased risk of breast cancer (seek guidance from menopause specialist or breast team).
• Thrombophilia disorder or past history of VTE (seek guidance from menopause specialist or haematologist).
• Factors predisposing to VTE (seek guidance from menopause specialist or haematologist).
• Previous thrombotic stroke or MI (seek guidance from menopause specialist).
• History of endometrial hyperplasia.
• Epilespy who use Lamotrigine.
• Porphyria cutanea tarda.
• Meningioma.
• Macroprolactinoma.
• Nut or soya allergy (contained in some HRT types).
• Veganism (gelatin and animal tallow is found in some HRT types).
• Lactose intolerance (most oral tablets contain lactose).